IGF1 and neoplasm: In conclusion, this study did not find evidence of an association of higher circulating free IGF-I, measured using a recently developed sandwich ELISA, with subsequent risk of prostate cancer overall or by follow-up duration and prostate tumor characteristics including histological grade, tumor stage and aggressiveness.